Darrell Shane Lea - 21 Nov 2022 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Chief Commercial Officer
Signature
/s/ Christina Blakley, Attorney in-fact for Darrell Shane Lea
Issuer symbol
CLRB
Transactions as of
21 Nov 2022
Net transactions value
$0
Form type
4
Filing time
15 Dec 2022, 16:00:43 UTC
Next filing
12 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +100,000 $0.000000 100,000 21 Nov 2022 Common Stock 100,000 $1.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in three equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continuous employment by the Issuer on each vesting date.